{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:50:18Z","timestamp":1791546618431,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:00:00Z","timestamp":1445299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11095-015-1806-z","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T00:43:09Z","timestamp":1445474589000},"page":"510-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["A Comparison of the Pharmacokinetics and Pulmonary Lymphatic Exposure of a Generation 4 PEGylated Dendrimer Following Intravenous and Aerosol Administration to Rats and Sheep"],"prefix":"10.1007","volume":"33","author":[{"given":"Gemma M.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Bischof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perenlei","family":"Enkhbaatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria M.","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda J.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J. H.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Kaminskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"issue":"4","key":"1806_CR1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1513\/pats.200409-049TA","volume":"1","author":"JS Patton","year":"2004","unstructured":"Patton JS, Fishburn CS, Weers JG. The lungs as a portal of entry for systemic drug delivery. Proc Am Thorac Soc. 2004;1(4):338\u201344.","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"1806_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrd2153","volume":"6","author":"JS Patton","year":"2007","unstructured":"Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov. 2007;6(1):67\u201374.","journal-title":"Nat Rev Drug Discov"},{"key":"1806_CR3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.addr.2012.09.031","volume":"64","author":"VP Torchilin","year":"2012","unstructured":"Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev. 2012;64:302\u201315.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"1806_CR4","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/jps.24353","volume":"104","author":"VM McLeod","year":"2015","unstructured":"McLeod VM, Chan LJ, Ryan GM, Porter CJH, Kaminskas LM. Optimal PEGylation can improve the exposure of interferon in the lungs following pulmonary administration. J Pharm Sci. 2015;104(4):1421\u201330.","journal-title":"J Pharm Sci"},{"issue":"6","key":"1806_CR5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s11095-012-0688-6","volume":"29","author":"L Baginski","year":"2012","unstructured":"Baginski L, Gobbo OL, Tewes F, Salomon JJ, Healy AM, Bakowsky U, et al. In vitro and in vivo characterisation of PEG-lipid-based micellar complexes of salmon calcitonin for pulmonary delivery. Pharm Res. 2012;29(6):1425\u201334.","journal-title":"Pharm Res"},{"issue":"2","key":"1806_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2009.08.005","volume":"140","author":"LM Kaminskas","year":"2009","unstructured":"Kaminskas LM, Kota J, McLeod VM, Kelly BD, Karellas P, Porter CJH. PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats. J Control Release. 2009;140(2):108\u201316.","journal-title":"J Control Release"},{"key":"1806_CR7","doi-asserted-by":"crossref","unstructured":"Ryan GM, Kaminskas LM, Porter CJH. Nano-chemotherapeutics: Maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers. J Control Release. 2014.","DOI":"10.1016\/j.jconrel.2014.04.051"},{"issue":"1\u20132","key":"1806_CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2014.05.027","volume":"471","author":"Y Tiantian","year":"2014","unstructured":"Tiantian Y, Wenji Z, Mingshuang S, Rui Y, Shuangshuang S, Yuling M, et al. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting. Int J Pharm. 2014;471(1\u20132):245\u201357.","journal-title":"Int J Pharm"},{"issue":"7493","key":"1806_CR9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature12978","volume":"507","author":"H Liu","year":"2014","unstructured":"Liu H, Moynihan KD, Zheng Y, Szeto GL, Li AV, Huang B, et al. Structure-based programming of lymph-node targeting in molecular vaccines. Nature. 2014;507(7493):519\u201322.","journal-title":"Nature"},{"issue":"1","key":"1806_CR10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2013.08.004","volume":"172","author":"GM Ryan","year":"2013","unstructured":"Ryan GM, Kaminskas LM, Bulitta JB, McIntosh MP, Owen DJ, Porter CJH. PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin. J Control Release. 2013;172(1):128\u201336.","journal-title":"J Control Release"},{"issue":"4","key":"1806_CR11","doi-asserted-by":"crossref","first-page":"e61646","DOI":"10.1371\/journal.pone.0061646","volume":"8","author":"IC Kourtis","year":"2013","unstructured":"Kourtis IC, Hirosue S, de Titta A, Kontos S, Stegmann T, Hubbell JA, et al. Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice. PLoS ONE. 2013;8(4):e61646.","journal-title":"PLoS ONE"},{"issue":"3","key":"1806_CR12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jamcollsurg.2011.11.006","volume":"214","author":"OV Khullar","year":"2012","unstructured":"Khullar OV, Griset AP, Gibbs-Strauss SL, Chirieac LR, Zubris KAV, Frangioni JV, et al. Nanoparticle migration and delivery of paclitaxel to regional lymph nodes in a large animal model. J Am Coll Surg. 2012;214(3):328\u201337.","journal-title":"J Am Coll Surg"},{"issue":"4","key":"1806_CR13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/02652049509087256","volume":"12","author":"CK Kim","year":"1995","unstructured":"Kim CK, Han JH. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. J Microencapsul. 1995;12(4):437\u201346.","journal-title":"J Microencapsul"},{"key":"1806_CR14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2014.03.012","volume":"183","author":"LM Kaminskas","year":"2014","unstructured":"Kaminskas LM, McLeod VM, Ryan GM, Kelly BD, Haynes JM, Williamson M, et al. Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy. J Control Release. 2014;183:18\u201326.","journal-title":"J Control Release"},{"issue":"3","key":"1806_CR15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/mp7001208","volume":"5","author":"LM Kaminskas","year":"2008","unstructured":"Kaminskas LM, Boyd BJ, Karellas P, Krippner GY, Lessene R, Kelly B, et al. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers. Mol Pharm. 2008;5(3):449\u201363.","journal-title":"Mol Pharm"},{"issue":"5","key":"1806_CR16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1021\/mp060032e","volume":"3","author":"BJ Boyd","year":"2006","unstructured":"Boyd BJ, Kaminskas LM, Karellas P, Krippner G, Lessene R, Porter CJ. Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats. Mol Pharm. 2006;3(5):614\u201327.","journal-title":"Mol Pharm"},{"issue":"8","key":"1806_CR17","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1021\/mp400091n","volume":"10","author":"GM Ryan","year":"2013","unstructured":"Ryan GM, Kaminskas LM, Kelly BD, Owen DJ, McIntosh MP, Porter CJH. Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent. Mol Pharm. 2013;10(8):2986\u201395.","journal-title":"Mol Pharm"},{"issue":"11","key":"1806_CR18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.addr.2007.08.023","volume":"59","author":"S-A Cryan","year":"2007","unstructured":"Cryan S-A, Sivadas N, Garcia-Contreras L. In vivo animal models for drug delivery across the lung mucosal barrier. Adv Drug Deliv Rev. 2007;59(11):1133\u201351.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1806_CR19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.pupt.2008.01.010","volume":"21","author":"WM Abraham","year":"2008","unstructured":"Abraham WM. Modeling of asthma, COPD and cystic fibrosis in sheep. Pulm Pharmacol Ther. 2008;21(5):743\u201354.","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"1806_CR20","first-page":"101","volume":"6","author":"EN Meeusen","year":"2009","unstructured":"Meeusen EN, Snibson KJ, Hirst SJ, Bischof RJ. Sheep as a model species for the study and treatment of human asthma and other respiratory diseases. Drug Discov Today: Dis Model. 2009;6(4):101\u20136.","journal-title":"Drug Discov Today: Dis Model"},{"issue":"2","key":"1806_CR21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.semperi.2013.01.001","volume":"37","author":"KH Albertine","year":"2013","unstructured":"Albertine KH. Progress in understanding the pathogenesis of BPD using the baboon and sheep models. Semin Perinatol. 2013;37(2):60\u20138.","journal-title":"Semin Perinatol"},{"issue":"10","key":"1806_CR22","first-page":"499","volume":"46","author":"M Las Heras Guillam\u00f3n De","year":"2010","unstructured":"De Las Heras Guillam\u00f3n M, Border\u00edas Clau L. The sheep as a large animal experimental model in respiratory diseases research. Arch Bronconeumol. 2010;46(10):499\u2013501.","journal-title":"Arch Bronconeumol"},{"issue":"5","key":"1806_CR23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tibtech.2008.02.002","volume":"26","author":"J-PY Scheerlinck","year":"2008","unstructured":"Scheerlinck J-PY, Snibson KJ, Bowles VM, Sutton P. Biomedical applications of sheep models: from asthma to vaccines. Trends Biotechnol. 2008;26(5):259\u201366.","journal-title":"Trends Biotechnol"},{"issue":"2","key":"1806_CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/15287398509530647","volume":"15","author":"RB Schlesinger","year":"1985","unstructured":"Schlesinger RB. Comparative deposition of inhaled aerosols in experimental animals and humans: a review. J Toxicol Environ Health. 1985;15(2):197\u2013214.","journal-title":"J Toxicol Environ Health"},{"issue":"5","key":"1806_CR25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-4804(75)90056-6","volume":"19","author":"NC Staub","year":"1975","unstructured":"Staub NC, Bland RD, Brigham KL, Demling R, Erdmann Iii AJ, Woolverton WC. Preparation of chronic lung lymph fistulas in sheep. J Surg Res. 1975;19(5):315\u201320.","journal-title":"J Surg Res"},{"key":"1806_CR26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1164\/rccm.200209-1031PP","volume":"167","author":"P Enkhbaatar","year":"2003","unstructured":"Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, Traber L, Phillips GB, et al. The iNOS inhibitor, BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injury. Am J Respir Crit Care Med. 2003;167:1021\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1806_CR27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/jps.24312","volume":"104","author":"SM Caliph","year":"2015","unstructured":"Caliph SM, Shackleford DM, Ascher DB, Kaminskas LM. Practical lessons in murine thoracic lymph duct cannulations: observations in female and male mice across four different strains that impact on \u201ccannulatability\u201d. J Pharm Sci. 2015;104(3):1207\u20139.","journal-title":"J Pharm Sci"},{"issue":"10","key":"1806_CR28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/00498250210158249","volume":"32","author":"JG Slatter","year":"2002","unstructured":"Slatter JG, Adams LA, Bush EC, Chiba K, Daley-Yates PT, Feenstra KL, et al. Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog. Xenobiotica. 2002;32(10):907\u201324.","journal-title":"Xenobiotica"},{"issue":"12","key":"1806_CR29","doi-asserted-by":"crossref","first-page":"e82965","DOI":"10.1371\/journal.pone.0082965","volume":"8","author":"RJ Prankerd","year":"2013","unstructured":"Prankerd RJ, Nguyen T-H, Ibrahim JP, Bischof RJ, Nassta GC, Olerile LD, et al. Pulmonary delivery of an ultra-fine oxytocin dry powder formulation: potential for treatment of postpartum haemorrhage in developing countries. PLoS ONE. 2013;8(12):e82965.","journal-title":"PLoS ONE"},{"issue":"9","key":"1806_CR30","first-page":"2653","volume":"5","author":"AE Hershey","year":"1999","unstructured":"Hershey AE, Kurzman ID, Forrest LJ, Bohling CA, Stonerook M, Placke ME, et al. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model. Clin Cancer Res. 1999;5(9):2653\u20139.","journal-title":"Clin Cancer Res"},{"key":"1806_CR31","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2147\/IJN.S29997","volume":"7","author":"P Zarogoulidis","year":"2012","unstructured":"Zarogoulidis P, Chatzaki E, Porpodis K, Domvri K, Hohenforst-Schmidt W, Goldberg EP, et al. Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomed. 2012;7:1551\u201372.","journal-title":"Int J Nanomed"},{"issue":"4","key":"1806_CR32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1183\/09031936.05.00017305","volume":"26","author":"F Gagnadoux","year":"2005","unstructured":"Gagnadoux F, Pape AL, Lemari\u00e9 E, Lerondel S, Valo I, Leblond V, et al. Aerosol delivery of chemotherapy in an orthotopic model of lung cancer. Eur Respir J. 2005;26(4):657\u201361.","journal-title":"Eur Respir J"},{"issue":"8","key":"1806_CR33","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1158\/1078-0432.CCR-06-1480","volume":"13","author":"BPH Wittgen","year":"2007","unstructured":"Wittgen BPH, Kunst PWA, van der Born K, van Wijk AW, Perkins W, Pilkiewicz FG, et al. Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung. Clin Cancer Res. 2007;13(8):2414\u201321.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1806_CR34","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1158\/1078-0432.CCR-06-1096","volume":"13","author":"GA Otterson","year":"2007","unstructured":"Otterson GA, Villalona-Calero MA, Sharma S, Kris MG, Imondi A, Gerber M, et al. Phase I study of inhaled doxorubicin for patients with metastatic tumors to the lungs. Clin Cancer Res. 2007;13(4):1246\u201352.","journal-title":"Clin Cancer Res"},{"key":"1806_CR35","unstructured":"Protein purification: principles, high resolution methods, and applications. 3rd ed. Janson J-C, editor: Wiley; 2012."},{"issue":"6","key":"1806_CR36","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1023\/A:1015851521551","volume":"9","author":"P Colthorpe","year":"1992","unstructured":"Colthorpe P, Farr SJ, Taylor G, Smith IJ, Wyatt D. The pharmacokinetics of pulmonary-delivered insulin: a comparison of intratracheal and aerosol administration to the rabbit. Pharm Res. 1992;9(6):764\u20138.","journal-title":"Pharm Res"},{"issue":"9","key":"1806_CR37","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1023\/A:1016281925554","volume":"12","author":"RW Niven","year":"1995","unstructured":"Niven RW, Whitcomb KL, Shaner L, Ip AY, Kinstler OB. The pulmonary absorption of aerosolized and intratracheally instilled rhG-CSF and monoPEGylated rhG-CSF. Pharm Res. 1995;12(9):1343\u20139.","journal-title":"Pharm Res"},{"issue":"5","key":"1806_CR38","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/jps.20053","volume":"93","author":"V Codrons","year":"2004","unstructured":"Codrons V, Vanderbist F, Ucakar B, Pr\u00e9at V, Vanbever R. Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1\u201334) from rat lungs. J Pharm Sci. 2004;93(5):1241\u201352.","journal-title":"J Pharm Sci"},{"issue":"11","key":"1806_CR39","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jps.2600751104","volume":"75","author":"J Mordenti","year":"1986","unstructured":"Mordenti J. Man versus beast: pharmacokinetic scaling in mammals. J Pharm Sci. 1986;75(11):1028\u201340.","journal-title":"J Pharm Sci"},{"key":"1806_CR40","unstructured":"Belvisi MG, Hele DJ. Animal models of cough. In: Chung FK, Boushey H, Widdicombe J, editors. Cough: causes, mechanisms and therapy: Wiley Online Library; 2007."},{"issue":"5","key":"1806_CR41","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1152\/jappl.1990.69.5.1670","volume":"69","author":"WD Bennett","year":"1990","unstructured":"Bennett WD, Foster WM, Chapman WF. Cough-enhanced mucus clearance in the normal lung. J Appl Physiol. 1990;69(5):1670\u20135.","journal-title":"J Appl Physiol"},{"issue":"6","key":"1806_CR42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/thx.49.6.557","volume":"49","author":"A Hasani","year":"1994","unstructured":"Hasani A, Pavia D, Agnew J, Clarke S. Regional lung clearance during cough and forced expiration technique (FET): effects of flow and viscoelasticity. Thorax. 1994;49(6):557\u201361.","journal-title":"Thorax"},{"issue":"1","key":"1806_CR43","first-page":"30","volume":"18","author":"JG Wal van der","year":"1988","unstructured":"van der Wal JG, Meyer JHF. Protein digestion in ruminants. S Afr J Anim Sci. 1988;18(1):30\u201341.","journal-title":"S Afr J Anim Sci"},{"issue":"3\u20134","key":"1806_CR44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/01902148509057524","volume":"9","author":"AD Chanana","year":"1985","unstructured":"Chanana AD, Joel DD. The ovine bronchopulmonary lymph drainage pathways: a model to study pulmonary immune responses. Exp Lung Res. 1985;9(3\u20134):211\u201320.","journal-title":"Exp Lung Res"},{"issue":"4","key":"1806_CR45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pathophys.2009.10.008","volume":"17","author":"DE Schraufnagel","year":"2010","unstructured":"Schraufnagel DE. Lung lymphatic anatomy and correlates. Pathophysiology. 2010;17(4):337\u201343.","journal-title":"Pathophysiology"},{"issue":"12","key":"1806_CR46","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/nbt.1696","volume":"28","author":"HS Choi","year":"2010","unstructured":"Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N, et al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol. 2010;28(12):1300\u20133.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"1806_CR47","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1152\/jappl.1989.67.5.1887","volume":"67","author":"MA Matthay","year":"1989","unstructured":"Matthay MA, Berthiaume Y, Albertine KH, Grady M, Fick G. Protein clearance from the air spaces and lungs of unanesthetized sheep over 144\u00a0h. J Appl Physiol. 1989;67(5):1887\u201397.","journal-title":"J Appl Physiol"},{"issue":"Pt 20","key":"1806_CR48","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1113\/jphysiol.2012.233403","volume":"590","author":"Y Buchackert","year":"2012","unstructured":"Buchackert Y, Rummel S, Vohwinkel CU, Gabrielli NM, Grzesik BA, Mayer K, et al. Megalin mediates transepithelial albumin clearance from the alveolar space of intact rabbit lungs. J Physiol. 2012;590(Pt 20):5167\u201381.","journal-title":"J Physiol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-015-1806-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-015-1806-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-015-1806-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T19:43:55Z","timestamp":1567280635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-015-1806-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["1806"],"URL":"https:\/\/doi.org\/10.1007\/s11095-015-1806-z","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]}}}